SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹10 Cr | ₹10 Cr | ₹8.57 Cr | ₹7.09 Cr | ₹6.83 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SAKAR HEALTHCARE ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹10 Cr |
| Mar2024 | ₹10 Cr |
| Mar2023 | ₹8.57 Cr |
| Mar2022 | ₹7.09 Cr |
| Mar2021 | ₹6.83 Cr |
How is Deferred Tax Assets / Liabilities of SAKAR HEALTHCARE Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹10 Cr | 3.18 | |
| Mar2024 | ₹10 Cr | 16.94 | |
| Mar2023 | ₹8.57 Cr | 20.87 | |
| Mar2022 | ₹7.09 Cr | 3.88 | |
| Mar2021 | ₹6.83 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹1,178.8 Cr | 3% | 11.6% | 122% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,470.0 Cr | -0.3% | 3.1% | 2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,996.0 Cr | 0.5% | -2.9% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,440.0 Cr | 0.1% | 1.4% | 37.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,417.0 Cr | 1.9% | 1.4% | 10.7% | Stock Analytics | |
| CIPLA | ₹101,445.0 Cr | -3.3% | -6.9% | -17% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 3% |
11.6% |
122% |
| SENSEX | -0% |
-10.7% |
1% |
You may also like the below Video Courses